Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.02% is 96% below its 5-year average of 0.48%, near the low end of its 5-year range (0.00%–1.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 81.80% below its 12-month average of 0.12%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 0.02%.
DEBT TO ASSETS RATIO
0.02%
DEBT TO ASSETS RATIO AVG TTM
0.12%
DEBT TO ASSETS RATIO AVG 3Y
0.41%
DEBT TO ASSETS RATIO AVG 5Y
0.48%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-81.80%
CURRENT VS 3Y AVG
-94.81%
CURRENT VS 5Y AVG
-95.63%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 848 covered companies
CURRENT VS SECTOR MEDIAN
-76.52%
vs the sector median at left
Bright Minds Biosciences Inc.
Market Cap
$475.46M
Debt to Assets Ratio
0.02%
TTM Avg
0.12%
3Y Avg
0.41%
5Y Avg
0.48%
Market Cap
$472.88M
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.16M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$464.23M
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$485.84M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $475.46M | 0.02% | 0.12% | 0.41% | 0.48% |
| Alpha Teknova, Inc. (TKNO)vs › | $472.88M | 0.29% | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $473.08M | 0.37% | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $470.21M | 0.03% | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.16M | 0.03% | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $476.17M | 0.01% | N/A | N/A | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $464.23M | 0.40% | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $485.84M | 0.02% | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.28M | 0.66% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $457.27M | 0.66% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
121.97
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.02% |
| 2026-03-31 | 0.03% |
| 2025-12-31 | 0.12% |
| 2025-09-30 | 0.15% |
| 2025-06-30 | 0.27% |
| 2025-03-31 | 0.30% |
| 2024-12-31 | 0.31% |
| 2024-09-30 | 1.95% |
| 2024-06-30 | 0.22% |
| 2024-03-31 | 0.53% |
| 2023-12-31 | 0.79% |
| 2023-09-30 | 1.07% |
| 2023-06-30 | 1.08% |
| 2023-03-31 | 1.08% |
| 2022-12-31 | 1.08% |
| 2022-09-30 | 1.16% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
